Top Markets
#1 Islamic Coin Islamic Coin +151.54%
#2 Akedo Akedo +66.39%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.78%
#5 Velvet Velvet +41.51%
#6 Cross Cross +35.02%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +20.45%
#9 DoubleZero DoubleZero +15.18%
#10 GRVT Token GRVT Token +9.99%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Rang in aandelen #39173
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Aandeelprijs
$0.378
Laatst gesynchroniseerd: 2024-05-24
Marktkapitalisatie
$618.41K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel NeuBase Therapeutics, Inc. (NBSE)

Categorie

Healthcare
Prijs NBSE met de marktkapitalisatie van B
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
NBSE
$0.378
Marktkapitalisatie van NeuBase Therapeutics, Inc.(NBSE)
Marktkapitalisatie: $618.41K
Vanaf August 2026 heeft NeuBase Therapeutics, Inc. een marktkapitalisatie van $618.41K. Dit maakt NeuBase Therapeutics, Inc. volgens onze gegevens het 39173rd meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van NeuBase Therapeutics, Inc. van 2004 tot 2026
NBSE vergeleken met de top 5 populairste stocks
Prijs voor NBSE Aandeel B Marktkapitalisatie van B uitslagen
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$3,343,238 $618.41K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +884,454,463.65%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,730,484 $618.41K
Apple Inc. Apple Inc.
AAPL
$4.467T +722,350,064.17%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,551,581 $618.41K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +675,021,304.38%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,261,661 $618.41K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +598,322,901.89%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$1,744,708 $618.41K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +461,562,929.50%